Nisa Investment Advisors
NKTR icon

Nisa Investment Advisors’s Nektar Therapeutics NKTR Stock Holding History

Nisa Investment Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44K Hold
20
– – ﹤0.01% 2671
2025
Q4 		$846 Sell
20
-5
-20% -$280 ﹤0.01% 2737
2025
Q3 		$1.42K Sell
25
-8
-24% -$265 ﹤0.01% 2683
2025
Q2 		$853 Sell
33
-43
-57% -$483 ﹤0.01% 2768
2025
Q1 		$779 Buy
76
+63
+485% +$823 ﹤0.01% 2696
2024
Q4 		$187 Sell
13
-8
-38% -$141 ﹤0.01% 2942
2024
Q3 		$412 Buy
+21
New +$400 ﹤0.01% 2754
2023
Q2 		– Sell
-1,687
Closed -$18K – 2843
2023
Q1 		$18K Buy
1,687
+954
+130% +$28.9K ﹤0.01% 2039
2022
Q4 		$25K Sell
733
-14
-2% -$678 ﹤0.01% 1996
2022
Q3 		$36K Sell
747
-62
-8% -$3.69K ﹤0.01% 1868
2022
Q2 		$46K Buy
809
+733
+964% +$46.2K ﹤0.01% 1760
2022
Q1 		$6K Sell
76
-1,111
-94% -$164K ﹤0.01% 2292
2021
Q4 		$198K Buy
1,187
+49
+4% +$10.6K ﹤0.01% 1272
2021
Q3 		$307 Sell
1,138
-975
-46% -$234K ﹤0.01% 1269
2021
Q2 		$544 Sell
2,113
-553
-21% -$153K ﹤0.01% 1121
2021
Q1 		$800 Buy
2,666
+400
+18% +$124K 0.01% 1040
2020
Q4 		$578K Buy
2,266
+361
+19% +$93.3K ﹤0.01% 1122
2020
Q3 		$474K Sell
1,905
-609
-24% -$192K ﹤0.01% 1060
2020
Q2 		$874K Buy
2,514
+1,153
+85% +$360K 0.01% 829
2020
Q1 		$364K Buy
1,361
+607
+81% +$188K ﹤0.01% 1029
2019
Q4 		$244K Buy
754
+109
+17% +$31.6K ﹤0.01% 1278
2019
Q3 		$176K Sell
645
-3,775
-85% -$1.38M ﹤0.01% 1353
2019
Q2 		$2.36M Buy
4,420
+976
+28% +$489K 0.02% 579
2019
Q1 		$1.74M Buy
3,444
+2,199
+177% +$1.3M 0.02% 658
2018
Q4 		$614K Sell
1,245
-2,617
-68% -$1.58M 0.01% 934
2018
Q3 		$3.53M Buy
3,862
+3,262
+544% +$2.78M 0.03% 466
2018
Q2 		$439K Sell
600
-1,280
-68% -$1.48M ﹤0.01% 1098
2018
Q1 		$3M Buy
1,880
+1,823
+3,198% +$2.35M 0.03% 484
2017
Q4 		$51K Hold
57
– – ﹤0.01% 1459
2017
Q3 		$20K Hold
57
– – ﹤0.01% 1531
2017
Q2 		$17K Hold
57
– – ﹤0.01% 1529
2017
Q1 		$20K Sell
57
-50
-47% -$11.2K ﹤0.01% 1503
2016
Q4 		$20K Hold
107
– – ﹤0.01% 1640
2016
Q3 		$27K Hold
107
– – ﹤0.01% 1545
2016
Q2 		$23K Hold
107
– – ﹤0.01% 1572
2016
Q1 		$22K Buy
+107
New +$20.6K ﹤0.01% 1576

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nisa Investment Advisors's NKTR Position: Q1 2026 in Review

Nisa Investment Advisors held its Nektar Therapeutics (NKTR) position steady in Q1 2026 at 20 shares worth $1.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Nisa Investment Advisors first reported a position in NKTR in Q1 2016 and has held it in 36 quarters since. The position peaked at $3.53M in Q3 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Nisa Investment Advisors held 20 shares of Nektar Therapeutics worth $1.44K as of Q1 2026.
  • Nisa Investment Advisors left its Nektar Therapeutics share count unchanged in Q1 2026.
  • Nektar Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2671 holding.
  • Nisa Investment Advisors first reported a position in Nektar Therapeutics in Q1 2016 and has held it in 36 quarters since.
  • Nisa Investment Advisors's Nektar Therapeutics position peaked at $3.53M in Q3 2018.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.